Ribonucleotide reductase small subunit p53R2 was identified as a p53 target gene that provides dNTP for DNA damage repair. However, the slow transcriptional induction of p53R2 in RNA may not be rapid enough for prompt DNA damage repair, which has to occur within a few hours of damage. Here, we demonstrate that p53R2 becomes rapidly phosphorylated at Ser 72 by ataxia telangiectasia mutated (ATM) within 30 min after genotoxic stress. p53R2, as well as its heterodimeric partner RRM1, are associated with ATM in vivo. Mutational studies further indicate that ATM-mediated Ser 72 phosphorylation is essential for maintaining p53R2 protein stability and conferring resistance to DNA damage. The mutation of Ser 72 on p53R2 to alanine results in the hyperubiquitination of p53R2 and reduces p53R2 stability. MDM2, a ubiquitin ligase for p53, interacts and facilitates ubiquitination of the S72A-p53R2 mutant more efficiently than WT-p53R2 after DNA damage in vivo. Our results strongly suggest a novel mechanism for the regulation of p53R2 activity via ATM-mediated phosphorylation at Ser 72 and MDM2-dependent turnover of p53R2 dephosphorylated at the same residue.
D
NA is surprisingly reactive and is under continuous assault from daily environmental agents such as UV light, reactive chemicals, and metabolic byproducts such as reactive oxygen species. Defects in DNA damage signaling and repair can lead to mutations, ultimately resulting in cancer (1) . In addition to a potential role in cancer development, damage to cellular DNA has been used for cancer therapy and is responsible for most of the toxic effects of such therapy (1, 2) . Therefore, the study of genes involved in DNA damage responses could lead to a deeper understanding of cancer development and more effective treatments of malignancies.
Ribonucleotide reductase (RR) is a rate-limiting enzyme responsible for providing a balanced dNTP supply for DNA synthesis and repair (3) . Unbalanced dNTP supply can lead to genetic abnormalities and cell death, underscoring the importance of the mechanisms that regulate RR activity. RR is composed of two nonidentical subunits, RRM1 and RRM2. p53R2, an analogue of RRM2 in mammalian cells, can substitute for RRM2 to interact with RRM1 and plays an important role in DNA damage induced by genotoxic stress (4, 5) . p53R2 has been identified as a transcriptional target of p53 (4), whereas RRM2 is transcriptionally regulated by cell cycle associated factors, such as nuclear factor Y and E2F (6) . However, the mechanism by which p53R2 activity is induced by p53 may not be rapid enough to supply dNTPs for prompt DNA repair, which can be completed within a few hours after DNA damage (1, 3) . More than 90% of damaged DNA can be repaired within 8 h after non-lethal UV irradiation in HeLa cells. Yet, the p53R2 mRNA is not fully induced until 12 h after ␥-irradiation in many of p53 WT cells including normal dermal fibroblast, MCF-7, LoVo, and HCT116 cell lines (4) . Additionally, we have previously observed that p53R2 can interact with p53 at the protein level to regulate RR activity (7) . These observations strongly suggested that the transcriptional induction of p53R2 via p53 may not be directly responsible for providing dNTPs for DNA repair after genotoxic stress.
To understand whether p53R2 activity is regulated via a posttranslational modification, we identified p53R2 as a direct substrate of ataxia telangiectasia mutated (ATM). p53R2 was phosphorylated by ATM at Ser 72 in vitro and in vivo. ATMdependent p53R2 Ser 72 phosphorylation regulates cell viability and p53R2 protein stability by inhibiting p53R2 hyperubiquitination and degradation by MDM2 in response to DNA damage. The mechanism of UV-induced S72A-p53R2 degradation will be discussed. 72 . We hypothesized that p53R2 activity can be regulated at the posttranslational level in response to DNA damage. Using in vivo 32 P-orthophosphate labeling, we have observed that 32 P can be incorporated into p53R2 induced by UV irradiation (Fig. 1A) , suggesting that p53R2 is a phosphorylated protein. The phosphatidylinositol-3 kinase-like (PIKK) family of kinases, including ATM and ATMand Rad3-related (ATR), are important in sensing DNA damage and initiating the subsequent signaling cascades (1, 8) . To explore if a signaling cascade exists between p53R2 and these PIKKs, we first examined whether p53R2 can be directly phosphorylated by PIKKs in vitro. Bacterially expressed full-length His-tagged p53R2 fusion proteins were used as a substrate in an in vitro kinase reaction with immunoprecipitated ATM from KB cells after UV irradiation. Recombinant p53R2 protein was strongly phosphorylated by the immunoprecipitated ATM at 30 min after UV exposure (Fig. 1B) . Immunoprecipitated ATR or DNA-PKcs was not able to phosphorylate p53R2 (data not shown). Furthermore, c-Jun N-terminal kinase immunoprecipitated from the same cell lysates efficiently phosphorylated its known substrate c-Jun (9) but not p53R2 [supporting information (SI) Fig. S1 ]. These results strongly suggested that p53R2 is a specific substrate for ATM. Examination of p53R2 amino acid sequences revealed two ATM consensus sites at Ser 72 K and Ser 112 Q. Alanine substitutions of these potential phosphorylation sites within p53R2 identified Ser 72 as a major site for phosphorylation by immunoprecipitated ATM. Compared with WT-p53R2, S72A-p53R2 (i.e., p53R2 with a single substitution at Ser 72 ) is less phosphorylated by immunoprecipitated ATM complex. Substitution at Ser 112 (S112A-p53R2) on p53R2 had no significant effect on its level of phosphorylation. A combination of both mutations (S72A/S112A-p53R2) did not result in any further reduction of phosphorylation compared with the S72A-p53R2 mutant (Fig. 1C) .
Results

ATM Phosphorylates p53R2 Predominantly at Ser
Ser 72 Phosphorylation by ATM Stabilizes p53R2 Protein Against UV
Irradiation. To confirm whether p53R2 is phosphorylated at Ser 72 in cells following genotoxic stress, a polyclonal antibody against phosphorylated Ser 72 of p53R2 (anti-pS72-p53R2) was generated. The anti-pS72-p53R2 antibody recognized WT-p53R2, but not the S72A-p53R2 mutant, after co-transfection with ATM plasmids. WT-p53R2 alone, without co-transfection with ATM plasmids, was not detected by this antibody (Fig. 2A) . Moreover, this antibody also detected an endogenous phosphorylated form of p53R2 induced by cisplatin, UV radiation, and ionizing radiation (IR; Fig. 2B ). We next examined the phosphorylation state of p53R2 in ATM-deficient fibroblasts derived from patients with ataxia-telangiectasia (A-T) after reconstitution without (pEBS7) or with (pEBS7-YZ5) ATM expression plasmids (10) . Re-introduction of the ATM gene into A-T cells restored Ser 72 phosphorylation of p53R2, as well as Ser 1981 phosphorylation of ATM induced by UV irradiation (Fig. 2C) . Surprisingly, p53R2 expressed in A-T cells (pEBS7) was rapidly degraded following UV exposure, whereas RRM1 and actin proteins remained unchanged (Fig. 2C ). p53R2 proteins in ATM reconstituted cells were resistant to UV-induced degradation. The S72A-p53R2 mutant transiently transfected in 293 cells also underwent UV-induced protein degradation, whereas WTp53R2 was stable (Fig. 2D) . Similar results were obtained in pulse-chase experiments (Fig. 2E) . UV induced rapid decay of S72A-p53R2, but failed to alter the amount of radiolabeled WT-p53R2 (Fig. 2E ). p53R2 degradation induced by UV in A-T cells can be blocked in cells pretreated with the proteasome inhibitor MG-132 (Fig. S2) , suggesting that UV-induced S72A-p53R2 decay is through the proteasomal pathway. Interestingly, polyubiquitinated forms of the S72A-p53R2 mutant were detected, but little WT-p53R2 ubiquitination was seen after coexpression with a ubiquitin expression plasmid in 293 cells following UV exposure (Fig. 2F ).
MDM2
Interacts with and Facilitates Ubiquitination of S72A Mutant p53R2 In Vivo. MDM2, an E3 ubiquitin ligase that targets p53 for proteasomal degradation, interacts with p53 dynamically in response to UV irradiation (11) . Given that p53R2 is a newly identified ATM substrate, we next tested whether MDM2 is involved in UV-induced ubiquitination and degradation of unphosphorylated p53R2. In transient transfection experiments, we found that co-expressing MDM2 promoted UV-induced polyubiquitination of S72A-p53R2 that was seen only in cells treated with the proteasome inhibitor MG132 (Fig. 3A) . To further investigate if MDM2 contributes to the degradation of p53R2, we examined endogenous p53R2 levels in MDM2-knockout mouse embryonic fibroblasts (MEFs) (12) in which ATM proteins were knocked down by siRNA. As shown in Fig.  S3 , p53R2 accumulated more in p53 Ϫ/Ϫ MDM2 Ϫ/Ϫ MEFs than in p53 Ϫ/Ϫ MEFs after UV irradiation. To further characterize the functional interaction between MDM2 and p53R2, we examined whether these two proteins interact. We first examined the interaction between endogenous p53R2 and MDM2 (Fig. 3B ). Using co-immunoprecipitation (co-IP) assays, we observed that MDM2 was present in the immunocomplexes of p53R2 before UV treatment (Fig. 3B) . The interaction between MDM2 and p53R2 was disrupted in ATM proficient cells (YZ5) at later time points after UV exposure (Fig. 3B, Left) . In contrast, endogenous p53R2 in ATM-deficient cells (pEBS7) remained associated with MDM2 after UV exposure (Fig. 3B , Right). This interaction was also detected between exogenously expressed MDM2 with WT-p53R2 or S72A-p53R2 in 293 cells before exposure to UV (Fig. 3C ). However, lower levels of MDM2 proteins dissociated from S72A mutant p53R2 compared with WT-p53R2 proteins following UV exposure. These results suggest that hyperubiquitination and degradation of S72A mutant p53R2 might result from a higher binding affinity with MDM2.
p53R2 and RRM1 Associate with ATM. To demonstrate a physical interaction between ATM and p53R2, we performed co-IP experiments. In support of the aforementioned observation that ATM is a direct p53R2 kinase, endogenous ATM and p53R2 were co-immunoprecipitated in UV-irradiated cells (Fig. 4A) . ATM was brought down by p53R2 specific antibodies as early as 15 min after UV irradiation (Fig. 4A ). This interaction was further verified by a reciprocal co-IP assay using ATM-specific antibody. However, when ATM antibody was used, p53R2 was already associated with ATM before UV irradiation (Fig. 4B) . Their interaction was clearly enhanced around 30 min after exposure to UV. In addition to p53R2 polypeptide, RRM1 (which has a molecular mass of 80 kDa) was also detected in the ATM immunoprecipitated complex. These results suggested that RRM1 and p53R2 can form a complex with ATM in vivo. However, p53R2 was not detected in ATR (Fig. 4C) or DNAPKcs immunocomplexes (Fig. 4D ). , Ser 112 (S112A), or both residues (S72A/S112A) were subjected to in vitro ATM kinase assay, and visualized by autoradiography and Coomassie staining as described earlier.
S72A-p53R2 Exerts a Dominant-Negative Effect in Cell Cycle
pressing Myc-tagged WT-, S72A-p53R2, or vector control were generated. Expression of the transgenes was assessed by immunoblotting analysis using a Myc-tagged specific antibody (Fig.  S4A ). All cell lines had a normal cell cycle distribution before UV exposure (Fig. 5A) . Following UV exposure, WT-p53R2 or vector control expressing cells exhibited a time-dependent decrease in G1 phase accompanied by an increase in S phase cells (0, 3, and 12 h) and a later increase in cells in G2/M phase (24 and 36 h). UV-induced G2/M arrested cells were slightly increased in WT-p53R2 transfected cells compared with vector transfected cells. However, such G2/M phase accumulation was not detected in S72A-p53R2 expressing cells. Instead, these cells accumulated predominantly in the S phase and decreased in the G1 phase. Most of the S72A-p53R2 expressing cells failed to enter the G2/M phase (Fig. 5A) . We also monitored the dynamic response of these cells to UV under an RT-CES system. There was no difference in cell growth among these cells without UV treatment (Fig. S4B) . However, S72A-p53R2 expressing cells resulted in a delayed growth curve compared with WT-p53R2 expressing cells, whereas vector control expressing cells had a growth curve between WT-and S72A-p53R2 expressing cells (Fig. S4B) .
Aberrant cell cycle progression may trigger a cell death response. We next used MTT assay to analyze the viability of those cells after exposure to genotoxic stress, including UV, IR, and cisplatin. As expected, S72A-p53R2 expressing cells are the most susceptible to all three genotoxic treatments (Fig. 5B) . Cells overexpressing p53R2 with a mutation at Ser 112 had a genotoxic sensitivity similar to that in cells expressing WTp53R2 (Fig. 5B) . These results strongly indicate an important role of ATM-dependent Ser 72 phosphorylation of p53R2 in protecting cells from genotoxic-induced cell death.
Discussion
Our results demonstrate that ATM phosphorylates p53R2 at Ser 72 in response to genotoxic stress and that this modification is essential for maintaining p53R2 protein stability. Mutation of Ser 72 to alanine rendered p53R2 both hyperubiquitinated and less stable than WT-p53R2 after UV irradiation. The role of ATM signaling has been implicated in the regulation of p53R2 protein expression (13) , but the underlying mechanism has not been clear. Here we present direct evidence that ATM not only phosphorylates but also interacts with p53R2. The phosphorylation of p53R2 at Ser 72 occurs at a time point that corresponds to the enhanced binding between p53R2 and ATM. The timing of phosphorylation at this site is also closely linked to the change in stability of p53R2 in A-T cells following UV irradiation. Therefore, we hypothesized that ATM-dependent phosphorylation at Ser 72 in p53R2 potentially contributes to its stability against UV induced degradation.
Its stability suggests that p53R2 is more functionally important than its RRM2 homologue when exposed to genotoxic stress. Unlike RRM2, p53R2 does not contain a KEN box sequence, which can be targeted by the Cdh1-APC E3 complex for proteolysis during G0/G1 arrest and late mitosis (14, 15) . However, we observed that endogenous p53R2 in A-T cells or S72A-p53R2 expressed in 293 cells was sensitive to UV exposure (Fig. 2) even though their mRNA levels remained unchanged (data not shown). Here we demonstrate that MDM2 promotes ubiquitination and degradation of S72A-p53R2. p53R2 protein accumulates in MDM2-deficient and ATM knockdown cells after UV exposure (Fig. S3) . Our data suggest that hyperubiq-MDM2, were preincubated with MG-132 for 30 min before exposure to UV (20J/m 2 ). At the indicated times, cells were lysed and immunoprecipitated with Myc-tagged antibody, followed by immunoblotting with MDM2 or Myctagged antibodies. uitination and degradation of S72A mutant p53R2 after UV stress might be a result of its strong binding with MDM2 ( Fig. 3  B and C) . MDM2 is well known for its role as a p53 ubiquitin ligase (11) . We found that p53R2, p53, and ATM can form a trimeric protein complex (Fig. S5 ), but whether p53R2 and p53 compete against each other as targets for MDM2 ubiquitination remains to be investigated. p53R2 has been implicated in the regulation of cell cycle progression induced by stress from DNA damage. p53R2-null cells or cells treated with the RR inhibitor hydroxyurea prevented G2/M arrest and resulted in cell death (4) . Similarly, cells overexpressing S72A-p53R2 exhibited abnormal cell cycle progression and enhanced sensitivity to genotoxic stress (Fig. 5) . As demonstrated in Fig. 4 , p53R2 constitutively interacts with RRM1. Therefore, overexpressed S72A-p53R2 might outcompete WT-p53R2 in binding RRM1 and disturb cell cycle progression. Measuring RR activity by the quantification of total dNTP revealed that overexpressed S72A-p53R2 reduced basal and UV-induced dNTP levels compared with WT-p53R2 and mock vector (Fig. S6 ).
Recent studies demonstrate that ATM regulates the function of p53R2 by providing dNTP for mitochondrial DNA synthesis (13, 16) . However, there seems to be no significant difference in the content of mtDNA in cells overexpressing WT-or S72A-p53R2 before or after UV exposure (Fig. S4C) . We previously identified a potential role of p53R2 in scavenging reactive oxygen species (ROS) and protecting mitochondrial membrane potential against oxidative stress-induced damage (17) . It will be of interest to determine whether the enhanced sensitivity of S72A-p53R2 expressing cells to genotoxic stress results from abnormal accumulation of reactive oxygen species.
In this study we demonstrate a direct link between p53R2 and ATM. Cells deficient either in ATM or p53R2 exhibit defects in DNA damage repair and cell cycle progression. p53R2 and RRM1 are normally expressed at low basal levels in resting cells, and both proteins can be translocated into the nucleus immediately upon genotoxic stress (4, 5) . Interestingly, p53R2 is detected in the MRE 11 complex (NBS1/Rad50/MRE11; Fig.  S7 ), a DNA damage complex involved in double-strand break repair and DNA damage checkpoint pathways (18) , further suggesting that p53R2 is part of the DNA damage complex. Similar to NBS1, p53R2 can pre-associate with ATM before UV stress (19) . Their interaction is enhanced after UV exposure. The increase in complexed ATM and p53R2 might be the result of conformational changes induced in the protein complex upon DNA damage. Recent evidence demonstrated that ATM at site-specific DSBs requires functional NBS1 protein, ATM kinase activity, and auto-phosphorylation of ATM at Ser 1981 (20) . Therefore, ATM may immediately recruit the preassociated RRM1 and p53R2 proteins along with the MRE11 complex to the DNA damage sites to supply dNTP during the acute phase of DNA damage repair. Weak or indirect interac- tions might explain why binding between p53R2 and ATR or DNA-PKcs was not observed (Fig. 4 C and D) . Interestingly, ATR's binding partner ATR-interacting protein (21), but not DNA-PKcs regulatory subunits Ku 70/80, can specifically interact with p53R2 (Fig. S8 ). This result suggested that p53R2 may also be involved in ATR-mediated DNA damage repair.
Defects in DNA damage repair may cause genomic instability and predispose cells to cancer. Epidemiological studies have linked ATM mutations to a high risk of breast cancer (22) . Moreover, a number of polymorphisms in the gene encoding p53R2 have been identified in esophageal squamous cell carcinoma and in colon carcinoma cells (23) (24) (25) , but none of these mutations are associated with altered p53R2 activity. A possible identification of Ser 72 mutation in breast cancer will further support the role of p53R2 in maintaining genomic integrity against cancer development. ATM and other proteins in its pathways have been studied as potential therapeutic targets to increase the sensitivity of cancer cells to DNA-damage agents (26) . The development of p53R2 small molecular inhibitors to block Ser 72 phosphorylation could be a potential therapy against malignancy.
Materials and Methods
Cells and UV Radiation. Cells were grown in DMEM supplemented with 10% FBS, 2 mM L-glutamine, 100 U/ml penicillin G, and 100 g/ml streptomycin. UV irradiation was performed with an UVC lamp (G8T5; General Electric). Dose rates were measured with a UVX Radiometer (UVP). For UV irradiation as well as for mock treatment, the growth medium was aspirated and the cell layer covered with a small amount of PBS solution. After treatment was completed, the growth medium was replenished.
[ 35 S]Methionine/Cysteine Pulse Chase Labeling. Pulse-chase experiments were performed as described previously (27) . Kinase Assays. ATM was immunoprecipitated from KB cells treated with or without UV irradiation and were used in kinase assays as previously described (28) . His-tagged recombinant p53R2 (5) or GST-cJun (1-79 aa) (28) proteins were added to the ATM immunocomplex G protein beads for the kinase reaction.
Immunoblotting Assays. Immunoblotting analysis was performed as described (27) . IRDye 680-conjugated rabbit or IRDye 800-conjugated mouse Ig-specific secondary antibodies (LI-COR) were used. Blocking buffer (LI-COR) was used to pretreat blots and dilute antibodies. The blots were imaged on an Odyssey Infrared Imaging System (LI-COR). Ubiquitination assays were performed as described previously (27) .
In Vivo 32 P Metabolic Labeling. In vivo labeling of 32 P-labeled polypeptides was performed as described previously (29) .
Cell Cycle Assays. KB stable cells expressing WT, S72A mutant p53R2, or empty vector were collected for fixation in methanol at the indicated time after UV irradiation. Following fixation, cells were washed and resuspended in PBS solution with 25 g/ml and 50 g/ml RNase 30 min before FACScan analysis. Analysis of the cell cycle results were performed using the ModFit LT program.
SI.
For real-time cell proliferation monitoring system, real-time quantitative PCR, RNA interference, and dNTPs pool assays, see SI Materials and Methods. Fig. S1 . p53R2 is not phosphorylated by JNK kinase after UV irradiation. Recombinant protein p53R2 (Top) and GST-cJun (1-77 aa; Bottom) as substrates were subjected to in vitro JNK immunocomplex kinase assay using the JNK immunoprecipitated from the same protein lysates as described in Fig. 1A . c-Jun is a known substrate for JNK (2) . S5 . Interaction between p53, p53R2, and ATM and increased interaction between p53 and p53R2. (A) Co-IP of endogenous ATM and p53 by antibodies to p53R2 and enhanced interaction between endogenous ATM, p53, and p53R2 after UV irradiation (20 J/m 2 ). The same experiment was performed in Fig. 3 except that p53R2 antibody was used for co-IP and anti-ATM, anti-p53, and anti-p53R2 antibodies were used to immunoblot. (B) Enhanced interaction between exogenous p53 and S72A-p53R2 mutant. The same experiment performed in Fig. 2 except that p53-GFP instead of MDM2 expression plasmid is co-transfected with other plasmids into 293 cells, and anti-ATM and anti-p53 antibodies were used to immunoblot the Myc-tagged immunoprecipitates. 
